The Flight Centre (ASX:FLT) share price is up 46% in November

The Flight Centre Travel Group Ltd (ASX:FLT) share price has been on fire in November. Here's why its shares are surging higher…

| More on:
Yellow paper plane flying high above other paper planes representing asx travel shares.

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The Flight Centre Travel Group Ltd (ASX: FLT) share price has been among the best performers on the S&P/ASX 200 Index (ASX: XJO) in November.

Since the start of the month, the travel agent giant's shares have risen a sizeable 46%.

This compares to an excellent gain of 10% by the benchmark index.

Why is the Flight Centre share price rocketing higher this month?

The catalyst for the strong Flight Centre share price gain this month has been news of two potentially effective COVID-19 vaccines.

This has sparked hopes that the global travel market could bounce back quicker than expected, which would be great news for Flight Centre. It is currently operating at a loss despite its rampant cost cutting.

What are the vaccines?

The first vaccine is being developed by biotech giant Pfizer and is a mRNA-based vaccine candidate named BNT162b2.

Last week it released the first set of results from a phase 3 COVID-19 vaccine trial.

In the first interim efficacy analysis, the vaccine candidate was found to be more than 90% effective in preventing COVID-19 in participants with no evidence of prior SARS-CoV-2 infection. This was significantly better than expectations.

Pfizer expects to produce up to 50 million vaccine doses globally in 2020 and then up to 1.3 billion doses in 2021.

The second vaccine, mRNA-1273, comes from US biotech Moderna. At the start of this week, it revealed that its Phase 3 study has met the statistical criteria pre-specified in the study protocol for efficacy, with a vaccine efficacy of 94.5%.

Moderna expects to have approximately 20 million doses of mRNA-1273 ready to ship in the U.S. by the end of the year. After which, it remains on track to manufacture 500 million to 1 billion doses globally in 2021.

Both vaccine candidates are using mRNA technology. This is a new approach to vaccines that uses genetic material to provoke an immune response.

What now for Flight Centre share price?

Two brokers that appear to have called time on the Flight Centre share price rally are Macquarie and Citi.

Last week they put neutral ratings and $13.50 and $16.00 price targets, respectively, on its shares. This compares to the current Flight Centre share price of $16.45.

Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia has recommended Flight Centre Travel Group Limited. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Share Gainers

three men stand on a winner's podium with medals around their necks with their hands raised in triumph.
Share Gainers

Here are the top 10 ASX 200 shares today

It was a happy end to the trading week this Friday.

Read more »

A business person directs a pointed finger upwards on a rising arrow on a bar graph.
Share Gainers

3 ASX 200 stocks storming higher in this week's sinking market

Investors have sent these three ASX 200 stocks soaring this week. But why?

Read more »

Two smiling work colleagues discuss an investment at their office.
Share Gainers

Why 4DMedical, Develop Global, EOS, and Maas shares are racing higher today

These shares are ending the week on a high. But why?

Read more »

Six smiling health workers pose for a selfie.
Healthcare Shares

Up 657% in a year, 4DMedcial shares rocketing another 20% today on big US news

ASX investors can’t get enough of 4DMedical shares today. Let’s see why.

Read more »

A neon sign says 'Top Ten'.
Share Gainers

Here are the top 10 ASX 200 shares today

The ASX 200 broke its losing streak to inch higher today.

Read more »

Wife and husband with a laptop on a sofa over the moon at good news.
Consumer Staples & Discretionary Shares

Bapcor shares soar 12% on the appointment of a new CEO

The market’s strong reaction reflects a clear message: investors are ready for a reset.

Read more »

A young woman drinking coffee in a cafe smiles as she checks her phone.
Share Gainers

Why Bapcor, IDP Education, Netwealth, and Ora Banda shares are pushing higher today

These shares are catching the eye with solid gains on Thursday. But why are they rising?

Read more »

Medical workers examine an xray or scan in a hospital laboratory.
Healthcare Shares

This ASX stock is going parabolic, and I think it's still a buy

4DMedical shares are up nearly 500% in 2025, but improving revenue visibility suggests the growth story may not be over.

Read more »